Few people in the US discuss their alcohol use in primary care; a practice facilitation shows promise in increasing screening ...
Substance use disorders (SUDs) in oncology populations represent a significant yet underrecognized challenge, with prior research suggesting that up to 27 percent of cancer patients meet criteria for ...
This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...
Getty Images The limited treatment options available for alcohol use disorder emphasize the urgent need for more research into pharmacologic therapies. While more research is needed, preclinical and ...
Ozempic and Wegovy weight loss drugs could help reduce alcohol use disorder symptoms, study suggests
The latest weight loss craze could also help people control their drinking. Semaglutide treatments such as Ozempic and Wegovy have been shown to reduce the symptoms of alcohol use disorder (AUD), ...
The first published evidence from humans that semaglutide specifically reduces the symptoms of alcohol use disorder (AUD) has been published in The Journal of Clinical Psychiatry and details a recent ...
Adial Pharmaceuticals has announced the issuance of patent number 12,226,401, which enhances their genetic-based approach for treating alcohol and opioid use disorders. This new patent focuses on ...
In a recent study published in the journal PLoS ONE, researchers investigated the effects of alcohol consumption and short-term abstinence on gut dysbiosis in individuals with Alcohol Use Disorder ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results